ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR ULCERATIVE COLITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY

William Sandborn  ¹     Bal R. Bhandari  ²     Charles Randall  ³     Ziad Younes  ⁴     Tomasz Romańczyk  ⁵     Hao Chai  ⁶     Matthew McKevitt     Sally Zhao     Bittoo Kanwar     John Sundy     Satish Keshav     Silvio Danese    
¹ University of California,San Diego,United States of America
² Delta Research Partners,Monroe,United States of America
³ Gastroenterology Research of America/U. of Texas,San Antonio,United States of America
⁴ GastroOne,Germantown,United States of America
⁵ Takeda Polska Sp. z o.o.,Tychy,Poland
⁶ Gilead Sciences,Foster City,United States of

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)